Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Anne J Lee & Ivan Goldberg. (2011) Emerging drugs for ocular hypertension. Expert Opinion on Emerging Drugs 16:1, pages 137-161.
Read now
Read now
Anne J Lee & Peter McCluskey. (2010) Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension. Clinical Ophthalmology 4, pages 741-764.
Read now
Read now
A Jayaprakash Patil, Thasarat S Vajaranant & Deepak P Edward. (2009) Bimatoprost – a review. Expert Opinion on Pharmacotherapy 10:16, pages 2759-2768.
Read now
Read now
David F Woodward$suffix/text()$suffix/text() & June Chen$suffix/text()$suffix/text(). (2007) Fixed-combination and emerging glaucoma therapies. Expert Opinion on Emerging Drugs 12:2, pages 313-327.
Read now
Read now
Articles from other publishers (7)
Prempal Kaur, Vishal Brar, Bhavkaran Singh Bal & Inderjit Kaur. (2016) A COMPARATIVE STUDY TO ASSESS THE EFFICACY AND TOLERABILITY OF LATANOPROST, BIMATOPROST AND TRAVOPROST IN PATIENTS WITH OPEN ANGLE GLAUCOMA. Journal of Evidence Based Medicine and Healthcare 3:44, pages 2169-2175.
Crossref
Crossref
Henny J. M. Beckers, Jan S. A. G. Schouten, Carroll A. B. Webers, Rikkert van der Valk & Fred Hendrikse. (2008) Side effects of commonly used glaucoma medications: comparison of tolerability, chance of discontinuation, and patient satisfaction. Graefe's Archive for Clinical and Experimental Ophthalmology 246:10, pages 1485-1490.
Crossref
Crossref
James D. Brandt, Louis B. Cantor, L. Jay Katz, Amy L. Batoosingh, Connie Chou & Izabella Bossowska. (2008) Bimatoprost/Timolol Fixed Combination: A 3-month Double-masked, Randomized Parallel Comparison to Its Individual Components in Patients With Glaucoma or Ocular Hypertension. Journal of Glaucoma 17:3, pages 211-216.
Crossref
Crossref
Jess T. Whitson & Nalini K. Aggarwal. 2008. Mechanisms of the Glaucomas. Mechanisms of the Glaucomas
611
644
.
A. Hommer, W. Benton BooneJames D. BranchLuca BrigattiWilliam C. ChristieWilliam S. CliffordDavid L. CookeJoel CorwinWilliam F. DavittIIIIIIJason BurnsDonald DigbyMark DiS-clafaniMartin DornerAnton HommerBarry KatzmanHartwig Koch-SchweitzerTheodore KrupinMark A. LatinaCharles LedererMartin R. LeopoldMark LeskArash MansouriDavid ManusowPaul MurphyKatherine OchsnerPeter Otto, Norbert PfeifferRoberto PiemontesiEugene Protzko, Bel AirRubin RubinRoman RybiczkaSon-ja ScholzelSriram SontyRobert H. StewartJoseph Tauber, Thomas R. Walters, Amy L. Batoosingh, Izabella Bossowska, Connie Chou, Alison Ingram & Gary D. Novack. (2018) A Double-Masked, Randomized, Parallel Comparison of a Fixed Combination of Bimatoprost 0.03%/Timolol 0.5% with Non-Fixed Combination use in Patients with Glaucoma or Ocular Hypertension. European Journal of Ophthalmology 17:1, pages 53-62.
Crossref
Crossref
Manali Doshi, Deepak P. Edward & Smajo Osmanovic. (2006) Clinical Course of Bimatoprost-Induced Periocular Skin Changes in Caucasians. Ophthalmology 113:11, pages 1961-1967.
Crossref
Crossref
F.J. Goñi, Veva de Groot, Mohamed El-Rifai, Ali Ahmed Khalifa, Taha Labib, Nabil Sabry, Sayid Saif, Leo de Jong, Khiun Fi Tjia, Willem Vaandrager, Ozana Cernica, Dorin Chiselita, Dumitru Ioan Vasinca, Francisco Javier Goñi, Concepcio Larena-Gomez, Miguel Teus-Guezala, Jose Luis Urcelay-Segura, Bertil Calel, Enping Chen, Kutay Andac, Belgin Izgi, Ozcan Ocakoglu, M. Erol Turacli, Izabella J. Bossowska & Alison M. Ingram. (2018) 12-Week Study Comparing the Fixed Combination of Brimonidine and Timolol with Concomitant Use of the Individual Components in Patients with Glaucoma and Ocular Hypertension. European Journal of Ophthalmology 15:5, pages 581-590.
Crossref
Crossref